Liver Transplant CGM
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorIcahn School of Medicine at Mount Sinai
About this trial
This investigator initiated study aims to describe continuous glucose monitoring (CGM) based glycemic metrics after discharge from liver transplant and assess relationship with glycemic metrics and liver transplant outcomes.
Eligibility criteria
Qualifiers
None
Disqualifiers
having a planned discharge to a rehabilitation or nursing facility,
a contraindication to sensor placement,
if discharge is anticipated to be >30 days post-transplant, or
if recent transplant also included a kidney or pancreas transplant
Trial design
Treatments tested in this trial
- Libre 3+
Treatment groups
40 Participants
are divided into 1 treatment groupLocations
1Mount Sinai Hospital10029, New YorkNew York, United States
Sponsors and collaborators
Icahn School of Medicine at Mount Sinai
Lead sponsor
Source ClinicalTrials.gov